Folate Analog Metabolic Inhibitor [EPC]

312342 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 55258
1 RHEUMATOID ARTHRITIS 28640
2 ARTHRALGIA 25703
3 PAIN 24984
4 FATIGUE 19821
5 OFF LABEL USE 17369
6 NAUSEA 17300
7 JOINT SWELLING 15790
8 HEADACHE 14612
9 DRUG INTOLERANCE 13600
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2363 0.9148
1 SWOLLEN JOINT COUNT INCREASED 467 0.9139
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 255 0.8763
3 PEMPHIGUS 4363 0.8128
4 RHEUMATIC FEVER 543 0.8104
5 RHEUMATOID FACTOR POSITIVE 2037 0.7929
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1311 0.7487
7 C-REACTIVE PROTEIN ABNORMAL 2078 0.6997
8 HAND DEFORMITY 4133 0.6619
9 SYNOVITIS 7048 0.6606
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]